SPA
CLB icon

Sherbrooke Park Advisers’s Core Laboratories CLB Stock Holding History

Sherbrooke Park Advisers’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,145
Closed -$176K – 661
2024
Q4 		$176K Buy
+10,145
New +$196K 0.06% 612

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sherbrooke Park Advisers's CLB Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 10,145 shares — an estimated $176K sold.

Sherbrooke Park Advisers first reported a position in CLB in Q4 2024 and held it in 1 quarter. The position peaked at $176K in Q4 2024. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 10,145 Core Laboratories shares in Q1 2025, an estimated $176K.
  • Sherbrooke Park Advisers first reported a position in Core Laboratories in Q4 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Core Laboratories position peaked at $176K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.